Contact Congress about S. 998: Medical Supply Chain Resiliency Act

The President could make trade deals that make it easier to import medicines, medical devices, and their parts from trusted countries. Congress would review each deal and could block it before it takes effect.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Medical Supply Chain Resiliency Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Finance.

Latest action on S. 998: Read twice and referred to the Committee on Finance.

Who this affects: This bill mainly affects companies that make, buy, sell, or ship medical goods across borders. It could also matter for hospitals, pharmacies, patients, and federal trade and health agencies because it may change how medical supplies move during normal times and emergencies.

Why this matters: Medical shortages can hit hard during pandemics and other health emergencies. This bill tries to make the U.S. less dependent on a small number of suppliers by building trade ties with trusted countries. It could help supplies move faster and more predictably. The real effect would depend on which countries join, what each deal says, and whether partners follow the rules.

Key provisions in S. 998

• The bill covers medical goods. That means human drugs, medical devices, and the parts or materials used to make them, across design, manufacturing, distribution, and other supply chain steps.
• The President could change tariffs and other import limits on medical goods. This can happen only through a trusted trade partner agreement that supports U.S. national security and public health.
• The President must review a country before starting talks. The review must look at open medical trade in emergencies, trade promises, rule of law, intellectual property, and regulatory practices.
• The deals could lower tariffs and quotas. They could also align rules, add suppliers, speed border checks, strengthen intellectual property rules, and exempt partners from some emergency trade limits.
• The President must keep Congress updated during talks. A status report is due every 180 days.

How Modern Action helps you take action on S. 998

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about S. 998

What is S. 998?

The President could make trade deals that make it easier to import medicines, medical devices, and their parts from trusted countries. Congress would review each deal and could block it before it takes effect.

How do I support or oppose S. 998?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about S. 998?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain S. 998 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.